1. Home
  2. SUPN vs NIC Comparison

SUPN vs NIC Comparison

Compare SUPN & NIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUPN
  • NIC
  • Stock Information
  • Founded
  • SUPN 2005
  • NIC 2000
  • Country
  • SUPN United States
  • NIC United States
  • Employees
  • SUPN N/A
  • NIC N/A
  • Industry
  • SUPN Biotechnology: Pharmaceutical Preparations
  • NIC Major Banks
  • Sector
  • SUPN Health Care
  • NIC Finance
  • Exchange
  • SUPN Nasdaq
  • NIC Nasdaq
  • Market Cap
  • SUPN 1.9B
  • NIC 1.8B
  • IPO Year
  • SUPN 2012
  • NIC N/A
  • Fundamental
  • Price
  • SUPN $33.56
  • NIC $129.22
  • Analyst Decision
  • SUPN Hold
  • NIC Buy
  • Analyst Count
  • SUPN 2
  • NIC 3
  • Target Price
  • SUPN $36.00
  • NIC $145.33
  • AVG Volume (30 Days)
  • SUPN 681.6K
  • NIC 116.7K
  • Earning Date
  • SUPN 08-05-2025
  • NIC 07-15-2025
  • Dividend Yield
  • SUPN N/A
  • NIC 0.99%
  • EPS Growth
  • SUPN N/A
  • NIC 26.37
  • EPS
  • SUPN 1.11
  • NIC 8.72
  • Revenue
  • SUPN $667,997,000.00
  • NIC $364,023,000.00
  • Revenue This Year
  • SUPN N/A
  • NIC N/A
  • Revenue Next Year
  • SUPN $15.74
  • NIC $4.08
  • P/E Ratio
  • SUPN $30.78
  • NIC $14.80
  • Revenue Growth
  • SUPN 11.82
  • NIC 10.19
  • 52 Week Low
  • SUPN $27.05
  • NIC $85.68
  • 52 Week High
  • SUPN $40.28
  • NIC $141.92
  • Technical
  • Relative Strength Index (RSI)
  • SUPN 57.11
  • NIC 47.55
  • Support Level
  • SUPN $32.94
  • NIC $130.85
  • Resistance Level
  • SUPN $34.21
  • NIC $135.21
  • Average True Range (ATR)
  • SUPN 1.06
  • NIC 4.22
  • MACD
  • SUPN 0.04
  • NIC -0.95
  • Stochastic Oscillator
  • SUPN 56.90
  • NIC 19.37

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About NIC Nicolet Bankshares Inc.

Nicolet Bankshares Inc is a United States-based bank holding company's principal business is banking, consisting of lending and deposit gathering, as well as ancillary banking-related products and services, to businesses and individuals of the communities it serves, and the operational support to deliver, fund and manage. It offers a variety of loans, deposits, and related services to business customers especially small and medium-sized businesses and professional concerns, business deposit products, cash management services, international banking services, business loans, lines of credit, commercial real estate financing, construction loans, agricultural real estate or production loans, and letters of credit, as well as retirement plan services.

Share on Social Networks: